About this trial
The purpose of this retrospective study was to characterize the changes in organ dysfunction among patients with acute necrotizing pancreatitis complicated by sepsis who underwent open necrosectomy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients 18 years or older
Diagnosis of Acute pancreatitis according to the revised Atlanta classification, requires two of thefollowing three criteria: (A) typical abdominal pain, (B) an increase in serum amylase or lipaselevels higher than three times the upper limit of normality, and (C) signs of AP in imaging3)Patients with confirmed or suspected infected pancreatic or peripancreatic necrosis werescheduled for open necrosectomy
Meet Sepsis-3 criteria
Disqualifiers
None
Trial population
This retrospective cohort included patients with acute necrotizing pancreatitis complicated by sepsis who underwent open necrosectomy
Trial design
Cohort
Retrospective
Treatments tested in this trial
Necrotizing Pancreatitis patients' organdysfunction progression
Other interventionStudy the dynamic nature of organ dysfunction
Treatment groups
Trial outcomes
Primary outcomes
Measure organ dysfunction change after open necrosectomy with respect to time
Organ dysfunction was assessed retrospectively using the Sequential Organ Failure Assessment (SOFA) score, which ranges from 0 (normal) to 4 (most abnormal) for each organ, with higher scores indicating more severe dysfunction.
Secondary outcomes
Incidence of ICU mortality
Incidence of hospital mortality
Incidence of 28-day mortality
Incidence of one year mortality
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: